Clinical Trial Update: Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completed Phase 1/Phase 2 study of AEE788 in patients with recurrent or relapsed glioblastoma multiforme. The study was s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• AEE788

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED